News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
704,983 Results
Type
Article (41326)
Company Profile (262)
Press Release (663395)
Multimedia
Podcasts (53)
Webinars (12)
Section
Business (205659)
Career Advice (2021)
Deals (35592)
Drug Delivery (99)
Drug Development (81594)
Employer Resources (172)
FDA (16339)
Job Trends (14944)
News (347754)
Policy (33014)
Tag
Academia (2600)
Accelerated approval (5)
Adcomms (21)
Allergies (88)
Alliances (50147)
ALS (89)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (126)
Approvals (16334)
Artificial intelligence (258)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11683)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (186)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (280)
Cancer (2279)
Cardiovascular disease (175)
Career advice (1688)
Career pathing (30)
CAR-T (152)
Cell therapy (433)
Cervical cancer (19)
Clinical research (66346)
Collaboration (844)
Compensation (529)
Complete response letters (21)
COVID-19 (2630)
CRISPR (41)
C-suite (244)
Cystic fibrosis (101)
Data (2206)
Decentralized trials (2)
Denatured (20)
Depression (44)
Diabetes (272)
Diagnostics (6403)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (101)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (86811)
Editorial (38)
Employer branding (21)
Employer resources (146)
Events (113153)
Executive appointments (726)
FDA (17608)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (754)
Gene editing (106)
Generative AI (20)
Gene therapy (312)
GLP-1 (717)
Government (4520)
Grass and pollen (4)
Guidances (65)
Healthcare (18900)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (122)
Indications (30)
Infectious disease (2775)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (312)
IPO (16573)
IRA (41)
Job creations (3672)
Job search strategy (1434)
Kidney cancer (10)
Labor market (38)
Layoffs (474)
Leadership (17)
Legal (7972)
Liver cancer (76)
Lung cancer (325)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (312)
MASH (67)
Medical device (13445)
Medtech (13450)
Mergers & acquisitions (19562)
Metabolic disorders (687)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (92)
Neuropsychiatric disorders (27)
Neuroscience (1933)
NextGen: Class of 2025 (6563)
Non-profit (4510)
Now hiring (39)
Obesity (364)
Opinion (212)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (84)
Parkinson's disease (148)
Partnered (22)
Patents (236)
Patient recruitment (111)
Peanut (49)
People (57692)
Pharmaceutical (65)
Pharmacy benefit managers (18)
Phase I (20692)
Phase II (29194)
Phase III (21785)
Pipeline (1202)
Policy (143)
Postmarket research (2578)
Preclinical (8813)
Press Release (71)
Prostate cancer (106)
Psychedelics (31)
Radiopharmaceuticals (246)
Rare diseases (387)
Real estate (5999)
Recruiting (65)
Regulatory (22632)
Reports (46)
Research institute (2359)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (43)
Schizophrenia (71)
Series A (131)
Series B (85)
Service/supplier (11)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (149)
Sponsored (30)
Startups (3630)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (31)
Vaccines (713)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (169)
Last 7 days (865)
Last 30 days (2657)
Last 365 days (33102)
2025 (10743)
2024 (35483)
2023 (40333)
2022 (51489)
2021 (56035)
2020 (54400)
2019 (46853)
2018 (35306)
2017 (32485)
2016 (31859)
2015 (37926)
2014 (31699)
2013 (26711)
2012 (28889)
2011 (29578)
2010 (27570)
Location
Africa (732)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38547)
Australia (6272)
California (6142)
Canada (2014)
China (529)
Colorado (267)
Connecticut (275)
Delaware (147)
Europe (82867)
Florida (911)
Georgia (206)
Idaho (57)
Illinois (535)
India (25)
Indiana (309)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (915)
Massachusetts (4599)
Michigan (220)
Minnesota (399)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1737)
New Mexico (28)
New York (1751)
North Carolina (972)
North Dakota (9)
Northern California (2679)
Ohio (207)
Oklahoma (14)
Oregon (35)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (33)
South America (1112)
South Carolina (22)
South Dakota (1)
Southern California (2308)
Tennessee (101)
Texas (906)
United States (23217)
Utah (182)
Virginia (145)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (54)
704,983 Results for "stc biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SiteOne Therapeutics Announces Positive Phase 1 Clinical Data for STC-004, a Novel NaV1.8 Inhibitor in Development for the Non-Opioid Treatment of Pain
February 4, 2025
·
2 min read
Drug Development
ASCO 2024: Brenus Pharma Presented “BreAK-CRC” First-in-human (FIH) Phase I/IIA Trial of STC-1010: a Next-generation Cancer Vaccine Targeting mCRC
Brenus Pharma, French biotech developing its proprietary discovery platform: “Stimulated-Tumor-Cell”, has presented the study design of “BreAK-CRC” First-in-human of STC-1010, Brenus’ lead candidate, during ASCO annual meeting - Trials in Progress poster session, in Chicago.
June 13, 2024
·
2 min read
Press Releases
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
March 7, 2025
·
6 min read
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
April 10, 2025
·
15 min read
Press Releases
MustGrow Signs Exclusive Distribution Agreement with Adjuvants Plus Inc. for Biological Product Line
February 11, 2025
·
8 min read
Press Releases
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
December 23, 2024
·
4 min read
Press Releases
Vivex Biologics, Inc. Provides Enrollment Update for its ASCEND Study Examining Whether Supplementing Discs with VIA Disc NP™ Reduces Pain and/or Improves Function in Patients with Symptomatic Disc Degeneration
April 9, 2025
·
2 min read
Press Releases
ADMA Biologics Statement on Tariffs
April 8, 2025
·
4 min read
Drug Development
Brenus Pharma Unveils Groundbreaking Preclinical Results For STC-10101, a Promising New Drug Candidate Targeting Colorectal Cancer & Solid Tumors
Brenus Pharma Announces two groundbreaking presentations on STC-1010, the company’s first drug candidate for colorectal cancer (CRC), produced by Brenus Pharma’s STC (Stimulated Tumor-Cells) Technology Platform.
April 27, 2023
·
4 min read
Press Releases
Bora Biologics Unveils Cutting-Edge Innovations at Festival of Biologics 2025
April 17, 2025
·
2 min read
1 of 70,499
Next
